Changeflow GovPing Healthcare USPTO Patent Grant for Reduced Pressure Therapy...
Routine Notice Added Final

USPTO Patent Grant for Reduced Pressure Therapy Apparatuses

Favicon for changeflow.com ChangeBridge: Patent Grants - Medical Devices (A61M)
Published March 24th, 2026
Detected March 25th, 2026
Email

Summary

The USPTO has granted a new patent (US12582762B2) for reduced pressure therapy apparatuses and methods of using them. The patent, assigned to Smith & Nephew PLC, covers specific pump assembly designs for wound therapy, including sterilization procedures.

What changed

The United States Patent and Trademark Office (USPTO) has issued patent US12582762B2 for "Reduced pressure therapy apparatuses and methods of using same." This patent, assigned to Smith & Nephew PLC, details a pump assembly for reduced pressure wound therapy. Key features include a housing, flow pathway, valves, a pump with a one-way flow valve, a pressure sensor, a user-accessible controller, and a sterilization process for all internal and external components.

This patent grant signifies a new intellectual property right for the assignee in the medical device sector, specifically for wound care technology. While not a regulatory rule imposing obligations on other entities, it establishes exclusive rights for the patent holder. Companies operating in the reduced pressure therapy space should be aware of this patent to avoid potential infringement and to inform their own product development strategies.

Source document (simplified)

← USPTO Patent Grants

Reduced pressure therapy apparatuses and methods of using same

Grant US12582762B2 Kind: B2 Mar 24, 2026

Assignee

Smith & Nephew PLC

Inventors

Julie Allen, Sarah Jenny Collinson, Edward Yerbury Hartwell, Derek Nicolini

Abstract

Some embodiments comprise a pump assembly for reduced pressure wound therapy, comprising a housing, a flow pathway through the pump, one or more valves in communication with the flow pathway, a pump supported within or by the housing, and a one-way flow valve in fluid communication with the pump. The pump assembly can have a pressure sensor in communication with the flow pathway through the pump, and at least one switch or button supported by the housing, the at least one switch or button being accessible to a user and being in communication with the controller. The one-way flow valve can be configured to substantially prevent a flow of gas through the one-way flow valve in a direction of flow away from the pump. The pump assembly can have a controller supported within or by the housing, the controller being configured to control an operation of the pump. The pump has been sterilized following the assembly of the pump such that an inside and an outside of the housing, the flow pathway, the one or more valves, the pump, the controller, the battery compartment, and the at least one switch or button have been sterilized.

CPC Classifications

A61M 1/962 A61M 1/732 A61M 1/74 A61M 1/78 A61M 1/80 A61M 1/90 A61M 2205/15 A61M 2205/18 A61M 2205/3334 A61M 2205/3344 A61M 2205/8212 A61M 2209/06 A61M 1/912 A61M 1/966 A61M 2205/42

Filing Date

2022-02-15

Application No.

17671996

Claims

20

View original document →

Named provisions

Reduced pressure therapy apparatuses and methods of using same

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
USPTO
Published
March 24th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US12582762B2

Who this affects

Applies to
Drug manufacturers Medical device makers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Medical Device Development Wound Therapy
Geographic scope
United States US

Taxonomy

Primary area
Medical Devices
Operational domain
Product Development
Topics
Wound Care Medical Technology

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Grants - Medical Devices (A61M) publishes new changes.

Free. Unsubscribe anytime.